Dottorato in Fisiopatologia Medica

• Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data. Gaia S, Campion D, Evangelista A, Spandre M, Cosso L, Brunello F, Ciccone G, Bugianesi E, Rizzetto M. Liver Int. 2015 Aug;35(8):2027-35. doi: 10.1111/liv.12761. Epub 2015 Jan 21. PMID: 25495478.

 

• Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cm. Guarneri A, Franco P, Trino E, Campion D, Faletti R, Mirabella S, Gaia S, Ragona R, Diotallevi M, Saracco G, Salizzoni M, Ricardi U, Carucci P. Med Oncol. 2016 Oct;33(10):104. doi: 10.1007/s12032-016-0823-z. Epub 2016 Aug 26. PMID: 27566310.

 

• Gastrointestinal tract disorders in the elderly. Durazzo M, Campion D, Fagoonee S, Pellicano R. Minerva Med. 2017 Dec;108(6):575-591. doi: 10.23736/S0026-4806.17.05417-9. Epub 2017 Sep 22. PMID: 28974085.

 

• The role of microbiota in autism spectrum disorders. Campion D, Ponzo P, Alessandria C, Saracco GM, Balzola F. Minerva Gastroenterol Dietol. 2018 Dec;64(4):333-350. doi: 10.23736/S1121-421X.18.02493-5. Epub 2018 Mar 30. PMID: 29600698.

 

• Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. Caraceni P, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, Levantesi F, Airoldi A, Boccia S, Svegliati-Baroni G, Fagiuoli S, Romanelli RG, Cozzolongo R, Di Marco V, Sangiovanni V, Morisco F, Toniutto P, Tortora A, De Marco R, Angelico M, Cacciola I, Elia G, Federico A, Massironi S, Guarisco R, Galioto A, Ballardini G, Rendina M, Nardelli S, Piano S, Elia C, Prestianni L, Cappa FM, Cesarini L, Simone L, Pasquale C, Cavallin M, Andrealli A, Fidone F, Ruggeri M, Roncadori A, Baldassarre M, Tufoni M, Zaccherini G, Bernardi M; ANSWER Study Investigators. Lancet. 2018 Jun 16;391(10138):2417-2429. doi: 10.1016/S0140-6736(18)30840-7. Epub 2018 Jun 1. Erratum in: Lancet. 2018 Aug 4;392(10145):386. PMID: 29861076.

 

• Non-invasive biomarkers for the detection of hepatocellular carcinoma. Campion D, Tucci A, Ponzo P, Caviglia GP. Minerva Biotecnologica 2019 March;31(1):11-22. doi: 10.23736/S1120-4826.18.02488-6

 

• HLA-DQ genotyping, duodenal histology, and response to exclusion diet in autistic children with gastrointestinal symptoms. Alessandria C, Caviglia GP, Campion D, Nalbone F, Sanna C, Musso A, Abate ML, Rizzetto M, Saracco GM, Balzola F. J Pediatr Gastroenterol Nutr. 2019 Jul;69(1):39-44. doi: 10.1097/MPG.0000000000002293. PMID: 31232884.

 

• Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis. Campion D, Giovo I, Ponzo P, Saracco GM, Balzola F, Alessandria C. World J Hepatol. 2019 Jun 27;11(6):489-512. doi: 10.4254/wjh.v11.i6.489. PMID: 31293718; PMCID: PMC6603507.

 

• Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial. Pose E, Napoleone L, Amin A, Campion D, Jimenez C, Piano S, Roux O, Uschner FE, de Wit K, Zaccherini G, Alessandria C, Angeli P, Bernardi M, Beuers U, Caraceni P, Durand F, Mookerjee RP, Trebicka J, Vargas V, Andrade RJ, Carol M, Pich J, Ferrero J, Domenech G, Llopis M, Torres F, Kamath PS, Abraldes JG, Solà E, Ginès P. Lancet Gastroenterol Hepatol. 2020 Jan;5(1):31-41. doi: 10.1016/S2468-1253(19)30320-6. Epub 2019 Oct 10. PMID: 31607677.

 

• Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF. Moreau R, Clària J, Aguilar F, Fenaille F, Lozano J, Junot C, Colsch B, Caraceni P, Trebicka J, Pavesi M, Alessandria C, Nevens F, Saliba F, Welzel TM, Albillos A, Gustot T, Fernández J, Moreno C, Baldasarre M, Zaccherini G, Piano S, Montagnese S, Vargas V, Genescà J, Solà E, Bernal W, Butin N, Hautbergue T, Cholet S, Castelli F, Jansen C, Steib C, Campion D, Mookerjee R, Rodríguez-Gandía M, Soriano G, Durand F, Benten D, Bañares R, Stauber RE, Gronbaek H, Coenraad MJ, Ginès P, Gerbes A, Jalan R, Bernardi M, Arroyo V, Angeli P; CANONIC Study Investigators of the EASL Clif Consortium, Grifols Chair and the European Foundation for the Study of Chronic Liver Failure (EF Clif). J Hepatol. 2020 Apr;72(4):688-701. doi: 10.1016/j.jhep.2019.11.009. Epub 2019 Nov 25. Erratum in: J Hepatol. 2020 Jun;72(6):1218-1220. PMID: 31778751.

 

• Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis. Fernández J, Angeli P, Trebicka J, Merli M, Gustot T, Alessandria C, Aagaard NK, de Gottardi A, Welzel TM, Gerbes A, Soriano G, Vargas V, Albillos A, Salerno F, Durand F, Bañares R, Stauber R, Prado V, Arteaga M, Hernández-Tejero M, Aziz F, Morando F, Jansen C, Lattanzi B, Moreno C, Campion D, Gronbaek H, Garcia R, Sánchez C, García E, Amorós A, Pavesi M, Clària J, Moreau R, Arroyo V. Clin Gastroenterol Hepatol. 2020 Apr;18(4):963-973.e14. doi: 10.1016/j.cgh.2019.07.055. Epub 2019 Aug 5. PMID: 31394283.

 

• The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. Trebicka J, Fernandez J, Papp M, Caraceni P, Laleman W, Gambino C, Giovo I, Uschner FE, Jimenez C, Mookerjee R, Gustot T, Albillos A, Bañares R, Janicko M, Steib C, Reiberger T, Acevedo J, Gatti P, Bernal W, Zeuzem S, Zipprich A, Piano S, Berg T, Bruns T, Bendtsen F, Coenraad M, Merli M, Stauber R, Zoller H, Ramos JP, Solè C, Soriano G, de Gottardi A, Gronbaek H, Saliba F, Trautwein C, Özdogan OC, Francque S, Ryder S, Nahon P, Romero-Gomez M, Van Vlierberghe H, Francoz C, Manns M, Garcia E, Tufoni M, Amoros A, Pavesi M, Sanchez C, Curto A, Pitarch C, Putignano A, Moreno E, Shawcross D, Aguilar F, Clària J, Ponzo P, Jansen C, Vitalis Z, Zaccherini G, Balogh B, Vargas V, Montagnese S, Alessandria C, Bernardi M, Ginès P, Jalan R, Moreau R, Angeli P, Arroyo V; PREDICT STUDY group of the EASL-CLIF Consortium. J Hepatol. 2020 Oct;73(4):842-854. doi: 10.1016/j.jhep.2020.06.013. Epub 2020 Jul 13. PMID: 32673741.

 

• On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites. Caraceni P, Tufoni M, Zaccherini G, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, Levantesi F, Airoldi A, Simone L, Svegliati-Baroni G, Fagiuoli S, Laffi G, Cozzolongo R, Di Marco V, Sangiovanni V, Morisco F, Toniutto P, Gasbarrini A, De Marco R, Piano S, Nardelli S, Elia C, Roncadori A, Baldassarre M, Bernardi M; ANSWER Study Investigators. J Hepatol. 2021 Feb;74(2):340-349. doi: 10.1016/j.jhep.2020.08.021. Epub 2020 Aug 24. PMID: 32853747.

 

• Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium. Solà E, Pose E, Campion D, Piano S, Roux O, Simon-Talero M, Uschner F, de Wit K, Zaccherini G, Alessandria C, Beuers U, Caraceni P, Francoz C, Mookerjee RP, Trebicka J, Vargas V, Serra M, Torres F, Montagnese S, Krag A, Hernaez R, Korenjak M, Watson H, Abraldes JG, Kamath PS, Ginès P; LiverHope Consortium Investigators. J Hepatol. 2021 Jan;74(1):200-219. doi: 10.1016/j.jhep.2020.08.009. Epub 2020 Sep 5. PMID: 32896580.

 

• Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure. Wong F, Piano S, Singh V, Bartoletti M, Maiwall R, Alessandria C, Fernandez J, Soares EC, Kim DJ, Kim SE, Marino M, Vorobioff J, Barea RCR, Merli M, Elkrief L, Vargas V, Krag A, Singh SP, Lesmana LA, Toledo C, Marciano S, Verhelst X, Intagliata N, Rabinowich L, Colombato L, Kim SG, Gerbes A, Durand F, Roblero JP, Bruns T, Yoon EL, Girala M, Pyrsopoulos NT, Kim TH, Yim SY, Juanola A, Gadano A, Angeli P; International Club of Ascites Global Study Group. J Hepatol. 2021 Feb;74(2):330-339. doi: 10.1016/j.jhep.2020.07.046. Epub 2020 Aug 8. PMID: 32781201.

 

• PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. Trebicka J, Fernandez J, Papp M, Caraceni P, Laleman W, Gambino C, Giovo I, Uschner FE, Jansen C, Jimenez C, Mookerjee R, Gustot T, Albillos A, Bañares R, Jarcuska P, Steib C, Reiberger T, Acevedo J, Gatti P, Shawcross DL, Zeuzem S, Zipprich A, Piano S, Berg T, Bruns T, Danielsen KV, Coenraad M, Merli M, Stauber R, Zoller H, Ramos JP, Solé C, Soriano G, de Gottardi A, Gronbaek H, Saliba F, Trautwein C, Kani HT, Francque S, Ryder S, Nahon P, Romero-Gomez M, Van Vlierberghe H, Francoz C, Manns M, Garcia-Lopez E, Tufoni M, Amoros A, Pavesi M, Sanchez C, Praktiknjo M, Curto A, Pitarch C, Putignano A, Moreno E, Bernal W, Aguilar F, Clària J, Ponzo P, Vitalis Z, Zaccherini G, Balogh B, Gerbes A, Vargas V, Alessandria C, Bernardi M, Ginès P, Moreau R, Angeli P, Jalan R, Arroyo V; PREDICT STUDY group of the EASL-CLIF CONSORTIUM. J Hepatol. 2021 May;74(5):1097-1108. doi: 10.1016/j.jhep.2020.11.019. Epub 2020 Nov 20. PMID: 33227350.

 

• Liver involvement in adult-onset Still's disease: our experience in a third level liver unit and review of the literature. Roma M, Bonetto S, Giovo I, Campion D, Rizzi F, Peroni CL, Saracco GM, Alessandria C.  Minerva Gastroenterol (Torino). 2021 May 12. doi: 10.23736/S2724-5985.21.02897-7. Epub ahead of print. PMID: 33978390.

 

• The Use of Rifaximin in Patients With Cirrhosis. Caraceni P, Vargas V, Solà E, Alessandria C, de Wit K, Trebicka J, Angeli P, Mookerjee RP, Durand F, Pose E, Krag A, Bajaj JS, Beuers U, Ginès P; Liverhope Consortium. Hepatology. 2021 Sep;74(3):1660-1673. doi: 10.1002/hep.31708. Epub 2021 Jun 7. PMID: 33421158.

 

• Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis. Pose E, Solà E, Lozano JJ, Juanola A, Sidorova J, Zaccherini G, de Wit K, Uschner F, Tonon M, Kazankov K, Jiménez C, Campion D, Napoleone L, Ma AT, Carol M, Morales-Ruiz M, Alessandria C, Beuers U, Caraceni P, Francoz C, Durand F, Mookerjee RP, Trebicka J, Vargas V, Piano S, Watson H, Abraldes JG, Kamath PS, Davis MM, Ginès P; investigators of the LIVERHOPE Consortium. Hepatol Commun. 2022 May;6(5):1100-1112. doi: 10.1002/hep4.1881. Epub 2021 Dec 28. PMID: 34964311.

 

• Assessment of glomerular filtration rate in patients with cirrhosis: Available tools and perspectives. Campion D, Rizzi F, Bonetto S, Giovo I, Roma M, Saracco GM, Alessandria C. Liver Int. 2022 Nov;42(11):2360-2376. doi: 10.1111/liv.15198. Epub 2022 Mar 21. PMID: 35182100.

 

• Transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease: Impact on renal function. Ponzo P, Campion D, Rizzo M, Roma M, Caviglia GP, Giovo I, Rizzi F, Bonetto S, Saracco GM, Alessandria C.  Dig Liver Dis. 2022 Aug;54(8):1101-1108. doi: 10.1016/j.dld.2021.09.008. Epub 2021 Oct 5. PMID: 34625366.

 

• Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Tertiary Care Center in North-West Italy. Ribaldone DG, Caviglia GP, Gaia S, Rolle E, Risso A, Campion D, Brunocilla PR, Saracco GM, Carucci P. Curr Oncol. 2022 Feb 24;29(3):1422-1429. doi: 10.3390/curroncol29030119. PMID: 35323319; PMCID: PMC8946861.

 

• Contrast-induced acute kidney injury (CI-AKI) in patients with cirrhosis: a prospective, multi-center, three-cohort study. Campion D, Ponzo P, Risso A, Caropreso P, Caviglia GP, Sanavia T, Frigo F, Bonetto S, Giovo I, Rizzo M, Martini S, Bugianesi E, Mengozzi G, Marzano A, Manca A, Saracco GM, Alessandria C. Submitted (Journal of Hepatology)

 

 

• Study of new algorithms for non-invasive staging of liver fibrosis in chronic viral hepatitis (CH) and non-alcoholic fatty liver disease (NAFLD). D. Campion, S. Gaia, M. Spandre, F. Brunello, A. Evangelista, L. Cosso, E. Bugianesi, S. Carenzi, P. Carucci, A. Cantamessa, G. Ciccone, M. Rizzetto. Digestive and Liver Disease - Abstracts of the 46^th A.I.S.F. Annual Meeting 2013 (p. S22) 

 

• Sorafenib versus ⁹⁰Y-radioembolization: a preliminary study on tolerability and survival in patients with advanced mono-lobar hepatocellular carcinoma. Gaia, M. Tabone, A. Cantamessa, D. Campion, P. Carucci, M. Grosso, A. Risso, P.R. Brunocilla, A. Calvo, F. Brunello, M. Rizzetto. Digestive and Liver Disease - Abstracts of the 46^th A.I.S.F. Annual Meeting 2013 (p. S42)

 

• Sorafenib versus radioembolization with Y90: clinical evaluation and survival in patients with advanced hepatocellular carcinoma and cirrhosis. Gaia, M. Tabone, A. Cantamessa, D. Campion, P. Carucci, M. Grosso, A. Risso, P.R. Brunocilla, A. Calvo, F. Brunello, M. Rizzetto. Journal of Hepatology 2013 (p. S109)

 

• Non-Invasive Score system for Fibrosis (NISF): A new staging model combining biochemical, elastographic and ultrasound data in chronic liver disease. D. Campion, S. Gaia, M. Spandre, A. Cantamessa, F. Brunello, A. Evangelista, L. Cosso, P. Carucci, E. Rolle, G. Ciccone, E. Bugianesi, S. Carenzi, M. Rizzetto. Digestive and Liver Disease 2014 (p. e3)

 

• Sorafenib versus Y90-Radioembolization: a preliminary assessment of tolerability and survival in advanced mono-lobar hepatocellular carcinoma. Cantamessa A, Gaia S, Tabone M, Campion D, Carucci P, Grosso M, Brunocilla PR, Risso A, Calvo A, Vesan M, Brunello F, Rizzetto M. Digestive and Liver Disease 2014 (p. e64)

 

• Sorafenib versus Y-radioembolization for advanced mono-lobar hepatocellular carcinoma in cirrhotic patients: a preliminary study on tolerability and survival. Gaia S, Cantamessa A, Tabone M, Campion D, Carucci P, Grosso M, Brunocilla PR, Risso A, Calvo A, Rolle E, Vesan M, Brunello F, Rizzetto M. Journal of Hepatology 2014 (p. S406)

 

• Non-invasive score system for fibrosis (NISF) in chronic liver disease: a new model combining biochemical, elastographic and ultrasound data. Gaia, D. Campion, M. Spandre, A. Cantamessa, F. Brunello, A. Evangelista, L. Cosso, P. Carucci, E. Rolle, G. Ciccone, E. Bugianesi, S. Carenzi, M. Rizzetto. Journal of Hepatology 2014 (p. S417)

 

• Stereotactic Ablative Radiotherapy in the Treatment of Hepatocellular Carcinoma Lesions Larger than 3 Centimeters. Diotallevi M, Carucci P, Guarneri A, Trino E, Campion D, Franco P, Mirabella S, Ragona R, Gaia S, Salizzoni M, Ricardi U, Rizzetto M. Journal of Hepatology 2016 (p. S571)

 

• Hepatocellular carcinoma and metabolic risk factors in a main reference center in Italy. Ibrahim Kamal Jouness R, Rosso C, Marietti M, Caviglia GP, Nascè A, Campion D, Cantamessa A, Carucci P, Bugianesi E. Digestive and Liver Disease 2017 (p. e36)

 

• Hepatocellular carcinoma and metabolic risk factors in a main reference center in Italy. Ibrahim Kamal Jouness R, Rosso C, Marietti M, Caviglia GP, Nascè A, Campion D, Cantamessa A, Carucci P, Bugianesi E. Journal of Hepatology 2017 (p. S623)

 

• Is stiffness reliable for the detection of liver fibrosis in HCV patients treated with direct acting antiviral drugs (DAAs)? A prospective cohort study. Gaia S, Vanni E, Campion D, Rolle E, Stradella D, Cortegoso Valdivia P, Evangelista A, Ciancio A, Smedile A, Trapani R, Saracco GM. Digestive and Liver Disease 2018 (p. 36)

 

• Safety and Tolerability of Two Doses of Simvastatin Associated with Rifaximin in Patients with Decompensated Cirrhosis. a Double-Blind, Randomized, Placebo-Controlled Trial. Pose E, Napoleone L, Amin A, Campion D, Jimenez C, Piano S, Roux O, Uschner F, de Wit K, Zaccherini G, Alessandria C, Angeli P, Bernardi M, Beuers U, Caraceni P, Durand F, P. Mookerjee Rajeshwar, Trebicka J, Vargas V, Gines P. Hepatology 2018 (p. 176A)

 

• Response to treatment and mortality in patients with acute-on-chronic liver failure according to the new definition of hepatorenal syndrome: a single center 3-year retrospective analysis. Giovo I, Campion D, Ponzo P, Rizzo M, Caviglia GP, Balzola F, Martini S, Torrani Cerenzia M, Saracco GM, Alessandria C. Digestive and Liver Disease 2019 (p. e44)

 

• Effective albumin concentration and albumin function improve after long-term albumin therapy in patients with decompensated cirrhosis. Baldassarre, M. Tufoni, G. Zaccherini, D. Campion, F.G. Foschi, S. Nardelli, F. Morisco, A. Federico, S. Massironi, A. Airoldi, F. Vizzutti, A. Antognoli, M. Gagliardi, C. Donadei, K.Waterstradt, M. Naldi, M. Bernardi, P. Caraceni. Digestive and Liver Disease 2020 (p. e14)

 

• Efficacy of transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome chronic kidney disease. Ponzo, M. Rizzo, D. Campion, I. Giovo, M. Roma, F. Rizzi, A. Risso, G.P. Caviglia, G.M. Saracco, C. Alessandria. Digestive and Liver Disease 2020 (p. e59)

 

• Terlipressin vs noradrenaline for the treatment of hepatorenal syndrome in patients with acute-on-chronic liver failure: a 5-year retrospective analysis. Giovo, M. Rizzo, P. Ponzo, D. Campion, M. Roma, F. Rizzi, A. Risso, G.P. Caviglia, F. Balzola, S. Martini, M. Torrani Cerenzia, G.M. Saracco, C. Alessandria. Digestive and Liver Disease 2020 (pp. e59-e60)

 

• Risk of contrast-induced acute kidney injury in cirrhotic patients undergoing computed tomography: myth or reality? D. Campion, M. Rizzo, P. Ponzo, A. Risso, I. Giovo, F. Rizzi, M. Roma, A. Risso, P. Caropreso, G.P. Caviglia, L. Colla, L. Biancone, A. Manca, G. Mengozzi, G.M. Saracco, C. Alessandria. Digestive and Liver Disease 2020 (p. e64)

 

• Simvastatin plus Rifaximin to prevent ACLF in patients with decompensated cirrhosis. A randomised, double-blind, placebo-controlled, phase-3 trial: the liverhope efficacy trial. E. Pose, C. Jiménez, G. Zaccherini, D. Campion, S. Piano, F. E. Uschner, K. de Wit, O. Roux, K. Gananandan, W. Laleman, C. Solé, S. Alonso, B. Cuyas, X. Ariza, A. Juanola, A. T Ma, L. Napoleone, J. Gratacos, M. Tonon, E. Pompili, J. Sánchez-Delgado, M. Carol, M. Perez, N. Fabrellas, J. Pich, C. Martell, G. Casanovas, G. Domenech, F. Torres, V. Manuel, V. Blasco, P. Caraceni, C. Alessandria, P. Angeli, J. Trebicka, U. Beuers, C. Francoz, R. Mookerjee, R. Bañares, G. Soriano, R. Hernaez, A. S. Allegretti, M. Morales-Ruiz, M. Serra, H. Watson, J. G. Abraldes, P. S. Kamath, P. Ginès. Journal of Hepatology 2023, Volume 78, Supplement 1 (p. S10-S11) [oral presentation]

 

7-9/10/2020 Online congress: 26° Congresso Nazionale delle Malattie Digestive FISMAD - Edizione Straordin-Air. Provider: FISMAD

11-12/12/2020 Online course: Hepatitis Sciences 2020 - Non solo virus. Provider: Health Data Consulting (Speaker).

8-10/03/2021 Online congress: 14th Paris Hepatology Conference - International Conference on the Management of Liver Diseases. Provider: Association for the Promotion of Hepatologic Care(APHC).

22-25/09/2021 Online congress: 27° Congresso Nazionale delle Malattie Digestive FISMAD. Provider: FISMAD

12/04/2022 Webmeeting FISMAD Piemonte - "Qualità in Endoscopia"

21-23/09/2022 Congress: XIV International Meeting on Therapy in Liver Diseases - Liverhope symposium. Provider: Liver Unit, Hospital Clinic, University of Barcelona

18-19/11/2022 Congress: Le IBD dal vecchio al nuovo millennio: il paziente al centro del percorso diagnostico-terapeutico e la IBD Unit (sogno o realtà?). Provider: Università degli Studi di Torino

26-27/05/2023 Congress: PBC Day - Paziente al centro, futuro intorno

23-24/06/2023 Course: Rediscover Mesalazine - Skill labs 2023. Provider: EventLab

 

 

29/01/2021 Online course: Corso di formazione generale alla salute e sicurezza per i lavoratori (art.37 del D.Lgs. 81/08). Provider: Università degli Studi di Torino.

13/02/2021 Online course (FAD): Clinical Risk Management: Conoscenze cliniche sui principali possibili errori attivi ed errori latenti nella Colite Ulcerosa e nel Morbo di Crohn. Provider: Mediserve s.r.l.

27/08/2021 Online course: La sicurezza trasfusionale. Provider: ASL TO3

17/09/2021 Online course: GDPR - Regolamento UE 2016/679 e sicurezza informatica. Provider: ASL TO3

29/10/2021 Executive course: Basic Life Support Defibrillation. Provider: Italian Resuscitation Council

02/12/2021 Webinar: Advanced Endoscopy Training from Maggiore Hospital, Crema 

24/02/2022 Webinar: Advanced Endoscopy Training from Maggiore Hospital, Crema - Quality for endoscopic examination of the stomach

6/04/2022 Online course: Formazione Generale alla Salute e Sicurezza per i Lavoratori (art.37 del DLgs 81/08). Provider: ASL TO3

14/11/2022 Online course: Neoassunti - Formazione Generale e Specifica alla Salute e Sicurezza per i Lavoratori (art.37 del DLgs 81/08) - Modulo per mansioni a rischio alto in area sanitaria - settore ATECO 2007 Q 86. Provider: AOU Città della Salute e della Scienza di Torino

17-19/04/2023 Liverhope Efficacy Trial Meeting

24/05/2023 Course: La gestione del paziente cirrotico con encefalopatia epatica tra ospedale e territorio. Provider: Scuola Piemontese Di Medicina Generale “Massimo Ferrua” (speaker)

27/09/2023 Course: Primo corso di Gastroenterologia in memoria del Dott. Rinaldo Pellicano. Provider: Università degli Studi di Torino

 

 

• 19/03/2021: PhD students' scientific presentations
• 29/07/2021: Fitting regression models: interpretation of regression coefficients, uncertainty measures and hypothesis testing. Prof. Maule
• 31/08/2021: Update on physiology of hypertension. Prof. Veglio
• 02/09/2021: Diabetic nephropathy. Prof. Gruden
• 06/09/2021: Precision medicine in oncology: Putting drivers and targets in context. Prof. Trusolino
• 13/09/2021: Targets for functional imaging in medicine. Prof. Deandreis
• 14/09/2021: Impact of the metabolic syndrome on the digestive tract. Prof. Bugianesi
• 23/09/2021: Regression models: from the linear model to the generalised linear models. Interpretation of interactions between predictors. Prof. Maule
• 14/06/2022: Monogenic forms of hypertension. Prof. Paolo Mulatero
• 01/09/2022: Diabetic nephropathy. Prof. Gabriella Gruden
• 14/09/2022: Precision medicine in oncology: Putting drivers and
  targets in context. Prof. Livio Trusolino 
• 25/10/2022: PhD students' scientific presentations
• 24/05/2023: Journal Club: Gastrointestinal complications of checkpoint inhibitors
• 31/05/2023: Alteration of intestinal microbioma as organ insufficiency: practical implications. Prof. De Rosa
• 6/06/2023: Biology and Diagnosis of SARS CoV2. Prof. Cristina Costa
• 8/06/2023: Cardiac electric physiopathological properties. Prof. Gaetano De Ferrari

 

• 2020 - 5/2021: Clinical Research Physician in hepatology at Gastroenterology Unit, AOU Città della Salute e della Scienza di Torino, Turin (Italy)

 

• 6/2021 - 10/2022: Resident Gastroenterologist and Endoscopist at Gastroenterology and Endoscopy Unit, Ospedale degli Infermi di Rivoli, Turin (Italy)

 

• 11/2022 - present day: Resident Gastroenterologist at Gastroenterology Unit, AOU Città della Salute e della Scienza di Torino, Turin (Italy)